Effect of gold nanoparticles on postoperative peritoneal adhesions in rats

Document Type : Research Paper


1 Department of Clinical Pharmacy, School of Pharmacy, Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad Iran

2 Endoscopic & Minimally Invasive Surgery Research Centre, Ghaem hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Immunology, Mashhad Branch, Islamic Azad University, Mashhad, Iran

4 Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran

5 Department of Anatomy, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran

6 Department of Pharmacology and Toxicology, School of Pharmacy, Zabol University of Medical Science

7 Medical Toxicology Research Center, School of Pharmacy, Mashhad University of Medical Science, Mashhad Iran


Abdominal adhesions are one of the most important problems, occurring after intra-abdominal surgery in more than 90% of cases. This condition is the leading cause of bowel obstruction, infertility, and abdominal/pelvic pain. Gold nanoparticles (GNPs) have been shown to be non-toxic and exhibit anti-inflammatory, anti-angiogenic and antioxidant activities. The purpose of this study was to determine the effect of intraperitoneal lavage with GNP solutions on the development of postoperative peritoneal adhesion (PPA).

Materials and Methods:
In the current experimental study, thirty-five male Wistar rats were randomly assigned to seven groups of five rats. After a standardized peritoneal injury, GNP solutions in different concentrations (1, 2.5, 5, 10, 50 and 100 ng/ml) were locally administered through nebulization; normal saline (NS) was administered to the control group. Two weeks later, the rats were sacrificed and cecum and peritoneal samples were harvested for histopathological assessment. Blood samples were obtained to determine serum concentrations of inflammatory biomarkers including tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β) and vascular endothelial growth factor (VEGF).

The rats treated with GNPs had significantly lower microscopic and macroscopic peritoneal adhesion scores, compared to the control group (P<0.05). Score 5 of macroscopic adhesions was reported in all the rats of the control group, unlike the GNP groups. Furthermore, microscopic adhesions were reported with all rats in the control group, unlike the GNP groups (reported in 0 out of 5 rats in all GNP groups). In addition, serum levels of IL-1β, TNF-α and VEGF underwent no significant changes.

Compared to the control group, GNPs decreased the severity of peritoneal adhesions, although they did not alter TNF-α, IL-1β or VEGF serum levels.


1. Whang SH, Astudillo JA, Sporn E, Bachman SL, Miedema BW, Davis W, et al. In Search of the Best Peritoneal Adhesion Model: Comparison of Different Techniques in a Rat Model. J Surg Res. 2011; 167(2): 245-250.
2. Jomezadeh V, Mohammadpour AH, Rajabi O, Tavassoli A, Maddah G . Evaluation of curcumin effects on post-operative peritoneal adhesion in rats. Iran J Basic Med Sci. 2012; 15(6): 1162-7.
3. Cheong YC, Laird SM, Shelton JB, Ledger WL, Li TC, Cooke ID. The correlation of adhesions and peritoneal fluid cytokine concentrations: a pilot study. Hum Reprod. 2002; 17(4): 1039-1045.
4. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Dig. sur., 2001; 18(4): 260-273.
5. Tsukada K, Katoh H, Shiojima M, Suzuki T, Takenoshita S, Nagamachi Y. Concentrations of cytokines in peritoneal fluid after abdominal surgery. Eur J Surg. 1993; 159(9): 475-9.
6. Kaidi AA, Nazzal M, Gurchumelidze T, Ali MA, Dawe EJ, Silva YJ. Preoperative administration of antibodies against tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) and their impact on peritoneal adhesion formation. Am Surg. 1995; 61(7): 569-72.
7. Cheong YC, Laird SM, Shelton JB, Ledger WL, Li TC, Cooke ID. The correlation of adhesions and peritoneal fluid cytokine concentrations: a pilot study. Hum Reprod.  2002; 17(4): 1039-1045.
8. Kim NH, Lee MY, Park SJ, Choi JS, Oh MK, Kim IS. Auranofin blocks interleukin‐6 signalling by inhibiting phosphorylation of JAK1 and STAT3. Immunology. 2007; 122(4): 607-614.
9. Kurukahvecioglu O, Koksal H, Gulbahar O, Erdem O, Engin D, Yazicioglu O, et al. Infliximab" TNF-alpha antagonist" decreases intraabdominal adhesions. Saudi Med. J., 2007; 28(12): 1830-1835.
10. Yoshida A, Anand-apte B, Zetter BR. Differential Endothelial Migration and Proliferation to Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor. Growth Factors.1996; 13(1-2): 57-64.
11. Saltzman AK, Olson TA, Mohanraj D, Carson LF, Ramakrishnan S. Prevention of postoperative adhesions by an antibody to vascular permeability factor/vascular endothelial growth factor in a murine model. Am J Obstet Gynecol, 1996; 174(5): 1502-6.
12. Diamond MP, El-Hammady E, Munkarah A, Bieber EJ, Saed G. Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril. 2005; 83(2): 405-9.
13. Cahill RA, Redmond HP. Cytokine orchestration in post-operative peritoneal adhesion formation. World J Gastroenterol. 2008; 14(31): 4861-4866.
14. Zheng Z, Zhang W, Sun W, Li X, Duan J, Cui J, et al. Influence of the carboxymethyl chitosan anti-adhesion solution on the TGF-β1 in a postoperative peritoneal adhesion rat. J Mater Sci Mater Med. 2013; 24(11): 2549-2559.
15. Yuzbasioglu MF, Kurutas EB, Bulbuloglu E, Goksu M, Atli Y, Bakan V, et al. Administration of honey to prevent peritoneal adhesions in a rat peritonitis model. Int J Surg. 2009; 7(1): 54-57.
16. Pal R, Panigrahi S, Bhattacharyya D, Chakraborti AS. Characterization of citrate capped gold nanoparticle-quercetin complex: Experimental and quantum chemical approach. J Mol Struct. 2013; 1046(0): 153-163.
17. Kalishwaralal K, Deepak V, Ram Kumar Pandian S, Gurunathan S. Biological synthesis of gold nanocubes from Bacillus licheniformis. Bioresour Technol. 2009; 100(21): 5356-5358.
18. Norton S. A brief history of potable gold. Vol. 8. 2008; 120-123.
19. Arvizo RR, Rana S, Miranda OR, Bhattacharya R, Rotello VM, Mukherjee P. Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine. 2011; 7(5): 580-587.
20. Dykman LA, Khlebtsov NG. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Naturae. 2011; 3(2): 34-55.
21. Tsai C-Y, Shiau A-L, Chen S-Y, Chen Y-H, Cheng P-C, Chang M-Y, et al. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum., 2007; 56(2): 544-554.
22. Carlson RV, Boyd KM, Webb DJ. The revision of the Declaration of Helsinki: past, present and future. Br J Clin Pharmacol. 2004; 57(6): 695-713.
23. BarathManiKanth S, Kalishwaralal K, Sriram M, Pandian S, Youn H-s, Eom S, et al. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnology. 2010; 8(1): 1-15.
24. DiZerega GS.Biochemical events in peritoneal tissue repair. Eur J Surg Suppl. 1997; (577): 10-16.
25. Thornton FJ, Barbul A.Healing in the gastrointestinal tract. Surg Clin North Am. 1997; 77(3): 549-573.
26. Eckes B, Nischt R, Krieg T.Cell-matrix interactions in dermal repair and scarring. Fibrogenesis & Tissue Repair. 2010; 3: 4-4.
27. Vykoukal D, Davies MG.Vascular biology of metabolic syndrome. J Vasc Surg. 2011; 54(3): 819-831.
28. Shah ZA, Vohora SB. Antioxidant/Restorative Effects of Calcined Gold Preparations Used in Indian Systems of Medicine against Global and Focal Models of Ischaemia. Pharmacology & Toxicology, 2002; 90(5): 254-259.
29. Saed GM, Munkarah AR, Diamond MP.Diamond, Cyclooxygenase-2 is expressed in human fibroblasts isolated from intraperitoneal adhesions but not from normal peritoneal tissues. Fertil Steril. 2003; 79(6): 1404-1408.
30. Greene AK, Alwayn IP, Nose V, Flynn E, Sampson D, Zurakowski D, et al.Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg. 2005; 242(1): 140.
31. Aysan E, Bektas H, Ersoz F.A new approach to postoperative peritoneal adhesions: prevention of peritoneal trauma by aloe vera gel. Eur J Obstet Gynecol Reprod Biol. 2010; 149(2): 195-198.
32. Pereira DV, Petronilho F, Pereira HR, Vuolo F, Mina F, Possato JC, et al.Effects of gold nanoparticles on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2012; 53(13): 8036-8041.